MRFF – Emerging Priorities and Consumer Driven Research Initiative – 2026 Post-Acute Sequelae of COVID-19
Overview
This grant supports medical research and innovation projects investigating Post-Acute Sequelae of COVID-19 (PASC) across four streams: biological pathway investigation, pre-clinical and early-phase clinical research, comparative studies of biological drivers, and large-scale evaluation of integrated care pathways. All applications must demonstrate meaningful co-design with consumers and reflect the complexity and heterogeneity of PASC.
Eligibility Requirements
Applications will only be accepted from approved MRFF Eligible Organisations listed on the NHMRC website. Applicants must satisfy all requirements in the Medical Research Future Fund – Emerging Priorities and Consumer Driven Research Initiative – 2026 Post-Acute Sequelae of COVID-19 Grant Opportunity Guidelines.
Relevant Industries
How to Apply
Applications are submitted through the official government portal. Review the eligibility criteria carefully before applying, and ensure all supporting documents are prepared.
Visit the official application page